Publications
Sheriff SK, Shohara RA, Dumican SB, Small EJ, Carroll PR, Chan JM. Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancer. Clinical prostate cancer. 2005. PMID: 15882480
Galsky MD, Small EJ, Oh WK, Chen I, Smith DC, Colevas AD, Martone L, Curley T, Delacruz A, Scher HI, Kelly WK. Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005. PMID: 15735119
George DJ, Halabi S, Shepard TF, Sanford B, Vogelzang NJ, Small EJ, Kantoff PW. The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005. PMID: 15756004
Modi S, Seidman AD, Dickler M, Moasser M, D'Andrea G, Moynahan ME, Menell J, Panageas KS, Tan LK, Norton L, Hudis CA. A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer. Breast cancer research and treatment. 2005. PMID: 15803362
Muss HB, Von Roenn J, Damon LE, Deangelis LM, Flaherty LE, Harari PM, Kelly K, Kosty MP, Loscalzo MJ, Mennel R, Mitchell BS, Mortimer JE, Muggia F, Perez EA, Pisters PW, Saltz L, Schapira L, Sparano J, American Society of Clinical Oncology. ACCO: ASCO core curriculum outline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005. PMID: 15728218
Blakely CM, Sintasath L, D'Cruz CM, Hahn KT, Dugan KD, Belka GK, Chodosh LA. Developmental stage determines the effects of MYC in the mammary epithelium. Development (Cambridge, England). 2005. PMID: 15689376
Diaz LS, Foster H, Stone MR, Fujimura S, Relman DA, Levy JA. VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity. Journal of immunology (Baltimore, Md. : 1950). 2005. PMID: 15661918
R.L. Olin, S.M. Luger, D.L. Porter, S.J. Schuster, D. Tsai, S. Nasta, A. Perl, A.W. Loren, S. Goldstein, P. Mangan, V. Sherry, K. Cunningham, B. Sachs, K. Hummel, E.A. Stadtmauer. Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma. Biology of Blood and Marrow Transplantation. 2005. PMID:
Miller KD, Chap LI, Holmes FA, Cobleigh MA, Marcom PK, Fehrenbacher L, Dickler M, Overmoyer BA, Reimann JD, Sing AP, Langmuir V, Rugo HS. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005. PMID: 15681523
Rini BI, Weinberg V, Small EJ. A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma. Cancer. 2005. PMID: 15612026
Wong R, Shahjahan M, Wang X, Thall PF, De Lima M, Khouri I, Gajewski J, Alamo J, Couriel D, Andersson BS, Donato M, Hosing C, Komanduri K, Anderlini P, Molldrem J, Ueno NT, Estey E, Ippoliti C, Champlin R, Giralt S. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2005. PMID: 15682071
Levy JA, Autran B, Coutinho R, Phair JP. Registration of clinical trials. AIDS (London, England). 2005. PMID: 15665791
Rini B, Wadhwa M, Bird C, Small E, Gaines-Das R, Thorpe R. Kinetics of development and characteristics of antibodies induced in cancer patients against yeast expressed rDNA derived granulocyte macrophage colony stimulating factor (GM-CSF). Cytokine. 2005. PMID: 15598439
Jordan JD, He JC, Eungdamrong NJ, Gomes I, Ali W, Nguyen T, Bivona TG, Philips MR, Devi LA, Iyengar R. Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII. The Journal of biological chemistry. 2005. PMID: 15657046
Bhakta NR, Oh DY, Lewis RS. Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment. Nature immunology. 2005. PMID: 15654342
Kenny PA, Enver T, Ashworth A. Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells. BMC cancer. 2005. PMID: 15642117
Haidet P, Kelly PA, Chou C, Communication, Cirriculum, and Culture Study Group. Characterizing the patient-centeredness of hidden curricula in medical schools: development and validation of a new measure. Academic medicine : journal of the Association of American Medical Colleges. 2005. PMID: 15618092
Shah NP. Loss of response to imatinib: mechanisms and management. Hematology. American Society of Hematology. Education Program. 2005. PMID: 16304378
Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, Prince RA. Detection of gliotoxin in experimental and human aspergillosis. Infection and immunity. 2005. PMID: 15618207
Saw CB, Loper A, Komanduri K, Combine T, Huq S, Scicutella C. Determination of CT-to-density conversion relationship for image-based treatment planning systems. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2005. PMID: 16112465